Key result
Combined aortic valve replacement, coronary artery bypass grafting, and living donor liver transplant were performed in a single setting for a patient with hepatocellular carcinoma.
Why the study?
Liver transplantation in patients with significant cardiac disease carries increased morbidity and mortality, with both sequential and combined cardiac surgery and liver transplant posing high perioperative risks.
Case Report (n=1)
Demonstrates the feasibility of performing combined aortic valve replacement, coronary artery bypass grafting, and living donor liver transplantation in a single setting.
Single-case feasibility does not support routine combined AVR+CABG+liver transplant; leaves open safety and outcomes in broader HCC cohorts.
Liver transplantation in patients with significant cardiac disease presents considerable challenges due to increased morbidity and mortality. Sequential cardiac surgery followed by liver transplant has traditionally been recommended, yet some centers now perform combined or concomitant cardiac surgery and liver transplant within the same setting. Both approaches carry high intra- and peri-operative risks. We present a case where aortic valve replacement, coronary artery bypass grafting, and living donor liver transplant were performed in a single setting for a patient diagnosed with hepatocellular carcinoma.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2025) conducted a case report in Hepatocellular carcinoma and significant cardiac disease (n=1). Combined aortic valve replacement, coronary artery bypass grafting, and living donor liver transplant was evaluated. Combined aortic valve replacement, coronary artery bypass grafting, and living donor liver transplant were performed in a single setting for a patient with hepatocellular carcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: